Wolahan · Journal of neuroscience research 2018 · single-arm interventional trial · n=11

Lactate supplementation in severe traumatic brain injured adults by primed constant infusion of sodium L-lactate.

Cited 24 times in the scientific literature.

Level 4 - case-series / case-control

Uncontrolled single-arm interventional physiological study

PubMed 28543565 · doi:10.1002/jnr.24085 · record verified 2026-08-30

What was done

Researchers administered a primed constant sodium L-lactate infusion to 11 adult neurocritical care patients with moderate-to-severe traumatic brain injury. Blood samples were collected before and periodically during the infusion to measure systemic metabolites and calculate the arteriovenous difference of lactate (AVDlac) and glucose to quantify global cerebral uptake.

What was found

Sodium L-lactate infusion converted net cerebral lactate release into net cerebral lactate uptake. Based on a mixed-effects model, doubling arterial lactate concentration from 0.92 to 1.84 mM shifted AVDlac from -0.078 mM to 0.090 mM. Systemic glucose levels did not change significantly, while significant increases from baseline occurred for alanine (30% [20 to 39]), glutamine (34% [24 to 43]), acetate (87% [60 to 113]), valine (40% [28 to 51]), and leucine (24% [16 to 32]).

Why it matters

This study provides preliminary human physiological evidence that exogenous lactate supplementation can switch the injured brain from net lactate excretion to net lactate consumption, supporting its potential role as an alternative cerebral fuel substrate.

Limits

The study is limited by a very small sample size (n = 11) and the absence of a control or placebo group. It evaluated only acute biochemical and metabolic indices; clinical endpoints, neurological recovery, and overall safety outcomes were not evaluated.

Cited by